Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
05/2003
05/21/2003EP1311482A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
05/21/2003EP1311478A1 Novel thiourea compounds and the pharmaceutical compositions containing the same
05/21/2003EP1311475A1 Novel aminocyclohexane derivatives
05/21/2003EP1311467A1 Method for producing phthalic anhydride
05/21/2003EP1311466A1 Method for the vapour-phase partial oxidation of aromatic hydrocarbons
05/21/2003EP1311253A2 Use of vitamin d derivatives as bone resorption inhibitors
05/21/2003EP1115701B1 Arylsulfonanilide ureas
05/21/2003EP1060155B1 Method for distilling mixtures containing butanediol
05/21/2003EP1047687B1 Process for the production of gamma-butyrolactone
05/21/2003EP1027316B1 Synthesis of aryl ethers, methods and reagents related thereto
05/21/2003CN1419639A Pipe joint assembly and method for using same
05/21/2003CN1109031C Bicycle-aromatic compound
05/21/2003CN1109030C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides
05/21/2003CN1109027C Process for preparing gamma-butyrolactone
05/21/2003CN1109026C Sidechain-beering taxanes like compounds
05/21/2003CN1109009C Method for producing aliphatic alcohols
05/20/2003US6566550 Substituted aromatic ethers as inhibitors of glycine transport
05/20/2003US6566547 Fungicides
05/20/2003US6566540 Anidepressant
05/20/2003US6566539 Catalyst regeneration by treatment with an oxidizing agent
05/20/2003US6566538 Substituted oxygen alicyclic compounds, including methods for synthesis thereof
05/20/2003US6566381 For therapy of arthritis, cancer, cardiovascular disorder, skin disorder, ocular disorder, inflammation and gum disease
05/20/2003US6566373 For therapy of osteoporosis, periodontitis, and arthritis
05/20/2003US6565997 Superior in vibration transmittability between ceramic substrate and piezoelectric
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/15/2003WO2003040133A1 Maleic acid derivative and curable composition containing the same
05/15/2003WO2003040122A1 Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
05/15/2003WO2003040121A1 Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl- and didesmethyl-metabolites of citalopram
05/15/2003WO2003040120A1 Process for the preparation of dronedarone
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003039746A1 Catalysts
05/15/2003WO2003039549A2 Selective antibacterial agents
05/15/2003WO2003039529A1 Selective antibacterial agents
05/15/2003WO2003039454A2 Beta-secretase inhibitors and methods of use
05/15/2003WO2003039231A2 Compounds and methods for treating transplant rejection
05/15/2003WO2002057298A3 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
05/15/2003US20030092919 Method for the preparation of citalopram
05/15/2003US20030092915 Using phase transfer catalyst and quaternary ammonium compound
05/15/2003US20030092761 Method for the preparation of citalopram
05/15/2003US20030092755 Novel prodrugs for antimicrobial amidines
05/15/2003US20030092738 Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activity
05/15/2003US20030092728 Antagonists of MCP-1 function and methods of use thereof
05/15/2003US20030092715 Aryl and biaryl compounds having MCH modulatory activity
05/15/2003US20030092708 Anticholesterol agents; cardiovascular disorders; antilipemic agents
05/15/2003US20030092702 Antiinflammatory agents; autoimmune disease; autoimmune diseases
05/15/2003US20030092140 Novel polyketides and antibiotics
05/15/2003US20030091859 Luminescent material for organic and polymer-based electro-luminescence element and other optical elements
05/15/2003US20030091510 Administering fungicide to mucous membrane
05/15/2003US20030089460 Process of generating o-xylene-air mixtures for the production of phthalic anhydride
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2465186A1 Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl- and didesmethyl-metabolites of citalopram
05/15/2003CA2464757A1 Selective antibacterial agents
05/15/2003CA2464736A1 Beta-secretase inhibitors and methods of use
05/15/2003CA2464717A1 Compounds and methods for treating transplant rejection
05/14/2003EP1310488A1 Fused bicyclic amide compounds and medicinal use thereof
05/14/2003EP1309582A1 Method for the preparation of citalopram
05/14/2003EP1309581A1 Method for the preparation of citalopram
05/14/2003EP1309580A1 Continuous process for the production of optically pure (s)-beta-hydroxy-gamma-butyrolactone
05/14/2003EP1309571A1 Non-steroidal inflammation inhibitors
05/14/2003EP1309537A2 Method for catalytically producing organic substances by partial oxidation
05/14/2003EP1309328A1 Cox-2 inhibitors and the prevention of the side effects of radiation therapy
05/14/2003EP1309315A2 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
05/14/2003EP1144354B1 Anhydride stabilization
05/14/2003EP0939756B1 A process for the stereoselective reduction of alpha,beta-unsaturated ketones
05/14/2003CN1418206A Method for preparation of 5-cyano-1 (4-fluorophenyl) -1, 3-dihydroisobenzofurans
05/14/2003CN1418205A method for preparation of citalopram
05/14/2003CN1418204A Method for production of spirocyclic tetronic acid derivatives
05/14/2003CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same
05/14/2003CN1418187A Carboxylic acid derivatives as IP antagonists
05/14/2003CN1417211A Prepn of vitamin C-RE complex
05/14/2003CN1417187A Optically active 2,3-dienol and dienol ester and their synthesis and use
05/13/2003US6562842 Osteoporosis, oral diseases
05/13/2003US6562817 Suppressants of the IgE production
05/13/2003US6562807 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity
05/13/2003US6562792 Hygromycin derivatives
05/08/2003WO2003037892A1 Compounds useful as reversible inhibitors of cysteine proteases
05/08/2003WO2003037853A1 Substituted thioacetamides
05/08/2003WO2003037847A1 Benzamide derivatives as antagonists of orexin receptors
05/08/2003WO2003037328A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
05/08/2003WO2003037326A1 Solid phase synthesis of chemical libraries
05/08/2003US20030088110 Novel chiral derivatives of hibiscus acid bearing lactone ring moiety, process for preparing the same and a convenient method for the large-scale isolation of hibiscus acid
05/08/2003US20030088104 Circular dichroism
05/08/2003US20030087945 Sulfonylaminocarboxylic acids
05/08/2003US20030087905 Containing a haloalkyl group: e.g., 3-((3-(3-trifluoromethoxyphenoxy) phenyl)((3-(1,1,2,2-tetrafluoroethoxy)phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol
05/08/2003US20030087890 Substituted carbocyclic or heterocyclic hydroxamic acid derivatives, e.g., (3R,4S)-N-hydroxy-1-methyl-3-(((4-((2-methyl-4 -quinolinyl)methoxylphenyl)sulfonyl)methyl)-4-piperidinecarboxamide
05/08/2003US20030087882 Antiinflammatory agents
05/08/2003CA2463770A1 Compounds useful as reversible inhibitors of cysteine proteases
05/08/2003CA2462206A1 Substituted thioacetamides
05/07/2003EP1308436A1 Calcium receptor antagonists
05/07/2003EP1307445A1 Benzofuran derivatives and their use as antibacterial agents
05/07/2003EP1307426A1 Amino diphenyl ethers and amido diphenyl ethers
05/07/2003EP1307196A1 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
05/07/2003EP1214316B1 Five membered-ring compounds and utilization thereof in liquid crystal mixtures
05/07/2003EP1204658B1 Benzofurylpiperazine serotonin agonists
05/07/2003EP1029297B1 Method of virtual retrieval of analogs of lead compounds
05/07/2003EP1019358B1 3,3-diarylpropylamines , their use and preparation
05/07/2003EP0998470B1 Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds
05/07/2003EP0889863B1 Surface modified carbonate materials
05/07/2003EP0799219B1 Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products
05/07/2003EP0792270B1 Use of 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxy chroman (LLU-alpha)
1 ... 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 ... 472